Trial Profile
PHASE II STUDY OF LAPATINIB IN EGFR/HER2NEU POSITIVE ADVANCED CHORDOMA
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 28 Mar 2012
Price :
$35
*
At a glance
- Drugs Lapatinib (Primary)
- Indications Chordoma
- Focus Therapeutic Use
- 28 Mar 2012 New trial record